Shirley X.Y.

Drug Development & Disease Diagnostics
Drug Safety
Molecular Basis of Drug Targets & Diseases

144 College Street
Toronto ON M5S 3M2

Shirley Wu’s laboratory conducts research centered on advanced pharmaceutics and drug delivery technologies for unmet medical needs. Our current projects include blood-brain barrier-penetrating nanoparticles for treatment and diagnosis of brain cancer and CNS diseases; synergistic drug combination nanomedicine for enhancing chemotherapy; bioreactive hybrid metal oxide nanoparticles for modulating tumor microenvironment and enhancing cancer therapies; rational and computer-aided design of controlled release dosage forms; stimulus-responsive systems for closed-loop delivery of therapeutic hormones for diabetes.


Keywords: drug delivery, cancer, diabetes, nanotechnology, micro technology, computer simulation, pharmaceutical, pharmacological, physiopathological, multidrug resistant, metastatic cancers, nanomaterials